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http://www.cardiothoracicsurgery.org/content/9/1/23RESEARCH ARTICLE Open AccessIs crystalloid cardioplegia a strong predictor of
intra-operative hemodilution?
Murat Günday1 and Hakan Bingöl2*Abstract
Introduction: Complications due to hemodilution (hematocrit value less than 22%) after cardiopulmonary bypass
inevitably resulted with significantly greater intensive care requirements, long hospital stays, more operative costs,
and increased mortality rates. We tried to identify whether crystalloid cardioplegia is the strongest predictor of
intraoperative hemodilution or not.
Materials and methods: One hundred patients were included into this randomized prospective study. Patients
were divided into the two groups. Crystalloid cardioplegia were given to the odd-numbered patients (Group 1,
n = 50 patients) and blood cardioplegia were given to the even-numbered patients (Group 2, n = 50 patients).
St. Thomas-II solution was used in Group-1 and Calafiore cold blood cardioplegia was in Group-2.
Results: Average intraoperative hematocrit value was 18.4% ± 2.3 in crystalloid group 24.2% ±3.4 in blood cardioplegia
group (p < 0.001). The lowest hematocrit value was 15% and 20% in two groups respectively (p < 0.001). In crystalloid
group average intraoperative packed red blood cell (RBC) transfusion was 2.3 ± 0.41 units, 0.7 ± 0.6 units blood
cardioplegia group (p = 0.001). Average transfused RBC was 2.7 ± 0.8 units in crystalloid group, 0.9 ± 0.4 units
blood cardioplegia group (p < 0.001). Multivariate analyses confirmed age (p = 0.005, OR = 3.78), female gender
(p = 0.003, OR = 2.91), longer cross-clamp time (>60 minutes) (p = 0.001, OD = 0.97), body surface area <1.6 m2
(p = 0.001, OR = 6.01) and crystalloid cardioplegia (p < 0.001, OR = 0.19) as predictor of intraoperative hemodilution.
Conclusion: Crystalloid cardioplegia, compared to blood cardioplegia not only causes much more intra-operative
hemodilution but also increases the blood transfusion requirement. Hemodilution and increased transfusion increases
the intensive care unit and hospital stay, in the early postoperative period.
Keywords: Cardioplegia, Crystalloid, Coronary artery, Bypass, HemodilutionBackground
The effect of hemodilution during cardiopulmonary
bypass is extensively studied and lower hematocrit levels
(< 22%) caused postoperative organ failure [1]. Renal fail-
ure, stroke, perioperative myocardial infarction, prolonged
mechanical ventilation and multiorgan failure are much
more common in hemodilution conditions [2]. There are
several predictors of hemodilution. Prebypass hematocrit
values (such as anemia), female gender, Cardiopulmonary
bypass (CPB) time, age, renal failure, and small body sur-
face area (BSA) are the strong predictor of hemodilution
and consequently blood transfusion [3-5]. We know that* Correspondence: hbingol@gmail.com
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article, unless otherwise stated.allogenic blood transfusion increases the risk of mortality
[6] and morbidity such as pulmonary edema [7], renal fail-
ure [8], transfusion complications [9]. There are lots of
surgeons still using Crystalloid Cardioplegia for its simpli-
city, economy and fairly good efficacy in the vast majority
of patients. Nevertheless, Crystalloid Cardioplegia presents
major disadvantages compared with the same volume
of blood cardioplegia [10]. It poorly supplies oxygen; it
increases the degree of hemodilution which is already high
after circulation of the priming volume and it decreases
the oncotic pressure [11]. As we mentioned negative ef-
fects of hemodilution and blood transfusion are clarified.
We have prospectively investigated the effects of Crystal-
loid Cardioplegia on hemodilution and necessity of blood
transfusion by comparing with blood cardioplegia.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Between 2010–2013, One hundred patients were included
into our randomized prospective study. We decided to
give Crystalloid cardioplegia to the odd-numbered patients
and blood cardioplegia to the even numbered patients.
Informed consents were obtained from all patients. Institu-
tional board approval from ethical committee of hospital
(Süleyman Demirel University, Faculty of Medicine) was
also obtained (November 13, 2006/3). Crystalloid cardio-
plegia (St. Thomas-II solution) have been used in Group-1.
Fifteen ml/kg St-Thomas II solution was given both
antegrade and retrograde initially. Then in every 20 minutes
St-Thomas II solution was given retrograde (7 ml/kg).
Just before cross-clamp removal 150 ml St-Thomas II
and 250 ml blood were given antegradely (Hot shot).
Calafiore blood cardioplegia was used in group-2 patients
[12,13]. This solution was given at the 600 ml warm solu-
tion and 600 ml cold solution in the induction period then
600 ml cold solution in every 20 minutes both antegradely
and retrogradely. Just before cross clamp removal 600 ml
warm blood cardiplegia (Hot Shot) with lower potassium
(4 mmol) was given antegradely (Table 1). Patients’ charac-
teristics were summarized in Table 2.
Operative characteristics
All patients in both groups had elective operations. All
patients underwent primary coronary revascularization.
CPB was done in all patients with two stage venous and
aortic cannula. Moderate hypothermia (26˚C) and topical
cooling with iced saline slush were used in all patients.
Myocardial preservation was accomplished as mentioned
previously in both groups. CPB was established with a
roller pump, non-pulsatile flow after anticoagulation with
bovine lung heparin (3 mg/kg) and activated clotting time
was maintained for more than 480 s. Membrane oxygena-
tors (Capiox-E Terumo Corp, Tokyo, Japan) were used.
Heparin was neutralized by protamine (3.5 mg/kg) at
the end of the CPB. All distal anastomoses were done
in a single cross-clamp period.
Transfusion protocols
Packed red blood cell transfusion was used when hema-
tocrit (Htc) levels were less than 22% during the intra-
operative period. Mostly Packed red blood cell (RBC)
added pump reservoir during the CPB period. Transfusion
was done when hematocrit < 18% in the postoperative
period. In older patients (>70 years old) Hct levels <20%
was accept as the lowest limit. Platelet transfusion andTable 1 Ingredients of calafiore cold blood cardioplegia solut
INDUCTION Native blood; 1000 ML Ringer solution; 70 mmol K+; 30 m
MAINTENANCE Same additives with induction
HOT SHOT 4 mmol K+fresh frozen plasma was limitedly used in both groups.
Fluid regime strictly followed during the postoperative
periods.
Sample size
According to our previous clinical observations, crystal-
loid cardioplegia reduces intraoperative Htc levels below
25% in coronary artery bypass graft (CABG) patients.
We predicted 10% reduction of Htc levels in blood car-
dioplegia patients. To detect this difference with 95%
confidence limits and power of 80% we needed to enter
at least 49 patients into each group [14].
Exclusion criteria
All re-operative and urgent and emergency procedures,
reoperations, bleeding disorders, dialysis dependent renal
failure, and anemic patients (preoperative Hct < 20%) were
excluded.
Statistical analyses
Statistical analysis was performed with SPSS software
version 10.0 (SPSS Inc., Chicago, IL). Clinical data were
expressed as mean values ± standard deviation. Differences
were analyzed with Fisher’s exact test, X2-test, unpaired
Student’s t-test and Mann–Whitney test. We investigated
the effects of the variables on hemodilution and transfu-
sion requirement by calculating odds ratios (OR) in univar-
iate analyses for all CABG patients. Variables for which the
unadjusted p-value was ≤0.20 in logistic regression analysis
were identified as potential risk markers and included
in the full model. We conducted stepwise multivariate
analyses by using logistic regression. We reduced the
model by using backward elimination and we eliminated
potential risk markers by using likelihood ratio tests.
Results
Average CPB time was 87 ± 14 minutes in crystalloid
group, 94 ± 11 in blood cardioplegia group (p = 0.301).
Average cross clamp time was 61 ± 15 and 58 ± 23 minutes
in both groups respectively (p = 0.433). Low cardiac output
developed in 11 patients in crystalloid and 5 patients in
blood cardioplegia group (p = 0.044). Positive inotropic
drugs were used in 17 patients in crystalloid cardioplegia
group, 8 patients in blood cardioplegia group (p = 0.032).
Intra-aortic balloon was inserted to five patients in crystal-
loid group and only one patient in blood cardioplegia
group. Dialysis required renal failure was developed only
one patient in crystalloid cardioplegia group. Four patientsion
l 8.4% NaHCO3; ratio “4/1 600 ml warm solution; 600 ml cold solution
600 ml cold solution
600 ml warm solution
Table 2 Preoperative characteristics of patients
Variable Crystalloid cardioplegia [no = 50] Blood cardioplegia [no = 50] p value
Age* 61 ± 12 63 ± 9 0.651
Male 37 39 0.466
Smoking 34 29 0.012
COPD 12 14 0.834
Hypertension 25 21 0.543
Congestive heart failure (no) 2 3 0.335
Peripheral vascular disease 11 9 0.746
Cerebral vascular disease 6 7 1.00
Average body surface area (BSA m2) 1.91 ± 0.5 1.89 ± 2.2 0.855
Body mass index (kg/m2)* 33.4 ± 4.2 29.3 ± 6.8 0.455
Ejection fraction (%)* 45.6 ± 7.8 50.1 ± 3.6 0.023
Preoperative IABP 2 - 0.242
Number of diseased vessels* (range 1–4) 2.1 ± 0.4 1.9 ± 0.6 0.744
LMCA disease (>50%) 5 3 0.721
Previous MI 31 37 0.462
Previous PTCA or stent 8 11 0.631
Preoperative hematocrit value (%) 38.5 ± 3.7 40.4 ± 5.6 0.563
Preoperative hemoglobine value (gr/dL) 13.3 ± 2.3 13.9 ± 2.9 0.646
*mean ± SD.
Abbrevations: COPD chronic obstructive pulmonary disease, IABP IABP intra-aortic balloon pump, LMCA left main coronary artery, MI myocardial infarction, PTCA
Percutaneous transluminal balloon angioplasty.
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and two patients in blood cardioplegia group (p = 0.677).
Radial artery was used in 17 patients in group 1 and 19
patients in group 2. LITA was used 45 patients in group
1 and 47 patients in group 2. Average intraoperative
hematocrit (%) value was 18.4 ± 2.3 in crystalloid group
24.2 ± 3.4 in blood cardioplegia group (p < 0.001). The
lowest Htc value was 15% and 20% in both groups
respectively (p < 0.001). 2.3 ± 0.41 units packed RBC
transfusion was necessary intra-operatively in crystal-
loid group, 0.7 ± 0.6 units in blood cardioplegia group
(p = 0.001). Average transfused RBC was 2.7 ± 0.8 units
in crystalloid group, 0.9 ± 0.4 units blood cardioplegia
group (p < 0.001). Mean intensive care unit (ICU) stay
was 2.7 ± 1.2 days in crystalloid group, 1.1 ± 0.45 days
in blood cardioplegia group (p = 0.001). Mean hospital
stay was 8.6 ± 2.1 versus 6.4 ± 1.1 days in respectively
(p < 0.001). Two patients died in crystalloid group but none
in blood cardioplegia group (p = 0.494). Perioperative and
postoperative variables were summarized in Table 3.
Predictors of intra-operative hemodilution
Data for all groups were combined and 11 variables were
subjected to statistical analysis as a predictor of intraop-
erative hemodilution (Htc < 22%). As shown in Table 4,
univariate analysis identified age (p = 0.009, OR = 2.07),
female gender (p = 0.007, OR = 0.89), longer cross-clamptime (>60 minutes) (p = 0.046, OD = 0.97), BSA <1.6 m2
(p = 0.005, OR = 5.60) and crystalloid cardioplegia (p <
0.001, OR = 0.36) as predictors of intraoperative hemo-
dilution. The value of −2 log likelihood of multivariate
analyses was 421.504. Multivariate analyses confirmed
five of six variables. These were age (p = 0.005, OR =
3.78), female gender (p = 0.003, OR = 2.91), longer
cross-clamp time (>60 minutes) (p = 0.001, OD =0.97),
BSA <1.6 m2 (p = 0.001, OR = 6.01) and crystalloid car-
dioplegia (p < 0.001, OR = 0.19).
Predictors of transfusion requirement of packed red
blood cells
Data for all groups were combined and 11 variables were
subjected to statistical analysis as a predictor of transfusion
requirement of packed red blood cell. As shown in Table 5
univariate analysis identified age (p = 0.034, OR = 3.1), fe-
male gender (p = 0.004, OR = 1.12), CPB time (p = 0.006,
OR = 2.33), longer cross-clamp time (>60 minutes) (p =
0.003, OD= 2.16), BSA <1.6 m2 (p = 0.001, OR = 3.71) and
crystalloid cardioplegia (p < 0.001, OR = 1.25) as predictors
of transfusion requirement. Multivariate analyses confirmed
five of six variables. These were female gender (p = 0.023,
OR = 3.91), CPB time (p = 0.001, OR = 1.7), longer cross-
clamp time (>60 minutes) (p = 0.001, OD = 4.45), BSA <1.6
m2 (p < 0.001, OR = 3.83) and crystalloid cardioplegia
(p < 0.001, OR = 0.78).
Table 3 Perioperative and postoperative variables
Variable Crystalloid cardioplegia [no = 50] Blood cardioplegia [no = 50] p value
CPB time (min) 87 ± 14 94 ± 11 0.301
Cross-clamp time 61 ± 15 58 ± 23 0.433
Distal anastomosis (range 1–4) 3.4 ± 0.9 3.1 ± 0.4 0.244
Low cardiac output 11 5 0.044
IABP 5 1 0.031
Positive inotropic drug requirement 17 8 0.032
Renal failure need dialysis 1 - 1
Revision
Tamponade 1 1 -
Bleeding 3 1 0.677
Ventilation >48 2 1 1.00
Sternal dehissence 3 - 0.242
TIA 1 1 -
Stroke 1 - -
Sternal wound infection 2 1 -
Mediastinitis 1 - -
Internal thoracic artery
-None 2 3 1.00
-Single 45 47 0.751
-Double 3 -
Radial artery 17 19 0.835
Saphenous vein 50 50 1.00
Average intraoperative Htc (%) 18.4 ± 2.3 24.2 ± 3.4 <0.001
Nadir intraoperative Htc (%) 15 20 <0.001
Average intraoperative Hb (gr/dL) 5.5 ± 1.2 6.7 ± 1.3 0.001
Average intraoperative transfusion of Packed RBC 2.3 ± 0.41 0.7 ± 0.6 0.001
Average transfusion of packed RBC 2.7 ± 0.8 0.9 ± 0.4 <0.001
Average FFP transfusion 2.1 ± 0.2 1.2 ± 0.8 0.001
Average platelet transfusion 1.2 ± 0.3 -
Mortality 2 - 0.494
ICU stay (days) 2.7 ± 1.2 1.1 ± 0.45 0.001
Hospital stay (days) 8.6 ± 2.1 6.4 ± 1.1 <0.001
SVT 29 21 0.008
Abbrevations: CPB cardiopulmonary bypass, IABP intra-aortic balloon pump, TIA transient ischemic attack, Htc Hematochrit, Hb Hemoglobine, RBC Red blood cell,
FFP fresh frozen packed, ICU intensive care unit, SVT supraventricular tachycardia.
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Cardioplegia protects the heart from ischemic injury and
postoperative heart failure during cardiopulmonary arrest
period. Initially crystalloid cardioplegia was introduced as
an agent to allow for hypothermic hyperkalemic arrest.
Various additives were explored to optimize the myocar-
dium during the time of ischemia [15]. Although cardio-
plegia is generally accepted to be a mandatory tool for
myocardial protection during on-pump cardiac surgery,
there is still controversy regarding various aspects includ-
ing its composition, temperature, and mode of delivery.Blood was then found to be the most logical vehicle for
delivery of potassium cardioplegia [16,17] The optimal
cardioplegic temperature, timing, and routes of delivery
were further explored [18]. There are still controversies
between crystalloid and blood cardioplegia for better myo-
cardial protection. Øvrum E. and colleagues [19] did not
found statistically significant differences between crystal-
loid and blood cardioplegia. Rinne T [20] demonstrated a
higher incidence of spontaneous resumption of sinus
rhythm after blood cardioplegia compared with that after
crystalloid cardioplegia. But Øvrum E and colleagues [19]
Table 4 Effects of various variables on the intraoperative hemodilution (Htc < 22) based on univariate and multivariate
logistic regression analyses
Univariate Multivariate
Unadjusted odds ratio 95% CI p value Adjusted* odds ratio 95% CI p value
Age 2.07 1.66-3.34 0.009 3.78 2.67-4.33 0.005
Female 0.89 0.42-1.85 0.007 2.91 1.99-3.01 0.003
Diabetes 0.99 0.55-1.88 0.712 1.66 0.2-5.43 0.476
EF 0.92 0.89-0.96 0.101 1.7 0.1-7.8 0.765
CPB time 1.03 0.99-1.10 0.211 2.6 2.1-2.91 0.001
X-clamp time > 60 0.97 0.91-1.05 0.046 0.97 0.94-1.03 0.001
COPD 3.41 2.13-4.29 0.111 3.94 2.35-6.99 0.178
LITA 0.49 0.25-0.81 0.023 0.65 0.32-1.25 0.230
Radial artery 0.75 0.36-1.42 0.442 2.11 1.01-3.36 0.536
BSA < 1.60 m2 5.60 4.71-8.95 0.005 6.01 5.67-6.33 0.001
Crystalloid cardioplegia 0.36 0.19-0.62 <0.001 0.19 0.08-0.35 <0.001
*Adjusted for ejection fraction, cross-clamp time, LITA, COPD.
EF ejection fraction, CPB cross-clamp time, LITA left internal thoracic artery, COPD chronic obstructive pulmonary disease, BSA body surface area.
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disturbances. Blood as opposed to crystalloid cardioplegia
could potentially improve postoperative cardiac outcomes,
because it more closely approximates normal physiology
caused in part by its oxygen carrying capacity and less
associated hemodilution [15].
Intraoperative hemodilution and transfusion requirement
becomes most critical subjects in the last decade [1-9].
Habib RH [1] specifically showed that major complications,
including stroke, myocardial infarction, low cardiac output
syndrome, renal failure, pulmonary edema, reoperation due
to bleeding, sepsis, and multiorgan failure, were increased
as the nadir hematocrit during CPB decreased. More-
over, this hematocrit–complications association inevitablyTable 5 Effects of various variables on the transfusion require
multivariate logistic regression analyses
Univariate
Unadjusted odds ratio 95% CI
Age 3.1 1.11-4.34
Female 1.12 0.92-1.85
Diabetes 1.23 0.95-2.88
EF 0.86 0.59-1.96
CPB time 2.33 1.99-3.10
X-clamp time > 60 min 2.16 1.91-2.55
COPD 4.61 1.13-7.29
LITA 2.34 0.25-4.81
Radial artery 2.45 1.31-4.02
BSA < 1.60 m2 3.71 3.34-4.95
Crystalloid cardioplegia 1.25 0.91-1.62
*Adjusted for ejection fraction, cross-clamp time, LITA, COPD.
EF ejection fraction, CPB cross-clamp time, LITA left internal thoracic artery, COPD chresulted in significantly and systematically greater inten-
sive care requirements, hospital stays, operative costs, and
death with increasing levels of hemodilution, particularly
for the lowest value less than 22%. Defoe and colleagues
[2] found that patients with a lower hematocrit during
cardiopulmonary bypass were associated with a higher
risk of in-hospital mortality. However they did not provide
data on transfusion or try to separate the effect of transfu-
sion versus anemia on in-hospital mortality. In addition,
somewhat unexpectedly, Habib RH [1] also found that
hemodilutional anemia on bypass was associated with
long-term adverse effects as well. Ongoren MC [6] found
that blood transfusion during or after cardiac operation
is associated with an increased risk of death over thement of packed red blood cell based on univariate and
Multivariate
p value Adjusted* odds ratio 95% CI p value
0.034 2.3 1.67-3.53 0.065
0.004 3.91 2.99-3.81 0.023
0.844
0.101
0.006 1.7 1.1-2.91 0.001
0.003 4.45 3.94-4.98 0.001
0.673
0.123
0.678
0.001 3.83 3.67-5.13 <0.001
<0.001 0.78 0.18-1.2 <0.001
ronic obstructive pulmonary disease, BSA body surface area.
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also had twice the 5-year mortality (15% vs 7%) of non-
transfused patients. After correction for comorbidities and
other factors, transfusion was still associated with a 70%
increase in mortality. We did not find statistically signifi-
cant difference for mortality between two groups. All these
statistical studies emphasized the importance of blood
saving both intra-operative and postoperative period.
Many blood precaution techniques has been developed
for reducing the risk of intra-operative hemodilution
and blood transfusion [8,9]. Predisposing factor for
intra-operative hemodilution and transfusion requirement
has been described. Multivariate analyses has proved that
previous anemia, female gender [13], low BSA, advanced
age, CPB time, and renal failure as predictor of intra-
operative hemodilution [2-9]. Hemodilution during CPB
results from the mixing of pump crystalloid and colloid
prime solution with the patient’s blood, and these two
relative volumes, along with pre-CPB, will largely deter-
mine the nadir value. In addition to above mentioned
variables, the type of cardioplegia also effects intra-
operative hemodilution. There weren’t any prospective
randomized study, identified crystalloid cardioplegia as
predictor of hemodilution and transfusion requirement.
Eucher PM noticed the hemodilutive effect of crystalloid
cardioplegia and described a technique to remove crystal-
loid cardioplegia by retrograde cardioplegia cannula
[14]. We performed this prospective randomized study
to identify cristalloid cardioplegia as the predictor of
hemodilution. Our multivariate study proved that above
mentioned variables (previous anemia, female gender,
low BSA, advanced age, CPB time, and renal failure) as
predictor of intra-operative hemodilution. But our multi-
variate analyses also proved that crystalloid cardioplegia is
also predictor of intraoperative hemodilution (p < 0.001,
OR = 0.19). Transfusion requirement predictors were
also well proved. Our study proved that crystalloid car-
dioplegia is also strong predictor of transfusion require-
ment (p < 0.001, OR = 0.78). The positive effects of blood
cardioplegia are well known. We won’t discuss this pre-
ventive ways of blood cardioplegia because of avoiding
confounding information.
Another alternative method for applying cardioplegia
is minicardioplegia. Its difference from blood cardioplegia
consists in the fact that it is applied without diluting the
blood in a ratio of 1/4 or 1/8. In the related literature it is
possible to find various publications on this topic. In their
study, Rıza Türköz et al. found that this method did
not necessitate too much volume during pumping and
prevented hemodilution from occurring at a high level,
while it ensured safe protection of the myocardium [21]. It
has been argued in another study that minicardioplegia
is more advantageous as regards myocardial edema after
ischemic damage [22]. In contrast to these findings,however, there also studies arguing that this method
does not provide any advantages over standard blood
cardioplegia [23].
Conclusion
Crystalloid cardioplegia, compared to blood cardioplegia
not only causes much more intra-operative hemodilution
but also increases the blood transfusion requirement.
Hemodilution and increased transfusion increases the
ICU and hospital stay, in the early postoperative period.
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